Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment

Overview of attention for article published in Frontiers in immunology, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 8 news outlets

twitter: 1 X user

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 4 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 8 news stories from 8 outlets.

Mendus publishes preclinical data demonstrating synergies of ilixadencel and 4-1BB-targeting immunotherapies

IT Business Net, 16 Aug 2023

INTRATUMORAL PRIMING BOOSTED THE THERAPEUTIC EFFICACY OF ANTI-4-1BB ANTIBODY TREATMENT AND RESULTED IN A MORE TREATMENT-SUPPORTIV…

Mendus publishes preclinical data demonstrating synergies of ilixadencel and 4-1BB-targeting immunotherapies

Biz Wire Express, 16 Aug 2023

GlobeNewswire 2023-08-16 INTRATUMORAL PRIMING BOOSTED THE THERAPEUTIC EFFICACY OF ANTI-4-1BB ANTIBODY TREATMENT AND RESULTED IN…

Mendus publishes preclinical data demonstrating synergies of ilixadencel and 4-1BB-targeting immunotherapies

Wall Street Online Denmark, 16 Aug 2023

INTRATUMORAL PRIMING BOOSTED THE THERAPEUTIC EFFICACY OF ANTI-4-1BB ANTIBODY TREATMENT AND RESULTED IN A MORE TREATMENT-SUPPORTIV…

News story from Finanz Nachrichten on Wednesday 16 August 2023

Finanz Nachrichten, 16 Aug 2023

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 4 additional news stories.